MONOTHERAPY WITH 4-4'DIISOAMYLOXYTHIO-CARBANILIDE (ISOXYL).
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D035843:Biomedical Research; D001799:Blood Sedimentation; D001831:Body Temperature; D001835:Body Weight; D002224:Carbanilides; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D005751:Gastric Lavage; D007538:Isoniazid; D010670:Phenylthiourea / Q000031:analogs & derivatives; D013183:Sputum; D013223:Statistics as Topic; D014116:Toxicology; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D002224:Carbanilides; C100189:thiocarlide; D010131:Aminosalicylic Acid; D010670:Phenylthiourea; D007538:Isoniazid
AMINOSALICYLIC ACID; ANTITUBERCULAR AGENTS; BLOOD SEDIMENTATION; BODY TEMPERATURE; BODY WEIGHT; CLINICAL RESEARCH; DRUG RESISTANCE, MICROBIAL; GASTRIC LAVAGE; ISONIAZID; SPUTUM; STATISTICS; THIOCARLIDE; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY